Thiazolidinediones for people with chronic kidney disease and diabetes

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

This review aims to assess the benefits and harms of thiazolidinediones in people with CKD and type 2 diabetes.

This is a protocol.

Published:

7 September 2023

Authors:

Natale P, Palmer SC, Tunnicliffe DJ, Toyama T, Strippoli GFM

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Natale P, Palmer SC, Tunnicliffe DJ, Toyama T, Strippoli GFM. Thiazolidinediones for people with chronic kidney disease and diabetes (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No.: CD015907. DOI: 10.1002/14651858.CD015907.